Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human beta-glucuronidase

EU orphan designation number: EU/3/12/973   
Active ingredient: Recombinant human beta-glucuronidase
Indication: Treatment of mucopolysaccharidosis type VII (Sly syndrome)
Sponsor: NDA Group AB
Johanneslundsvägen 2, Oxfordhuset, 194 81 Upplands Väsby, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2012 Centralised Orphan - Designation EMA/OD/127/11 (2012)2017 of 21/03/2012
02/01/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/127/11/T/01 (2013)9815 of 20/12/2013